These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16294546)

  • 1. [Anaemia, cardiac failure and erythropoietin].
    Cohen Solal A; Beauvais F
    Arch Mal Coeur Vaiss; 2005 Oct; 98(10):997-1001. PubMed ID: 16294546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaemia in diabetes.
    Thomas S; Rampersad M
    Acta Diabetol; 2004 Mar; 41 Suppl 1():S13-7. PubMed ID: 15103543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-erythropoietin effects on ventricular remodeling, left and right systolic function, pulmonary pressure, and hospitalizations in patients affected with heart failure and anemia.
    Palazzuoli A; Silverberg DS; Calabrò A; Spinelli T; Quatrini I; Campagna MS; Franci B; Nuti R
    J Cardiovasc Pharmacol; 2009 Jun; 53(6):462-7. PubMed ID: 19455052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anaemia and heart failure: aetiology and treatment.
    Klutstein MW; Tzivoni D
    Nephrol Dial Transplant; 2005 Jul; 20 Suppl 7():vii7-10. PubMed ID: 16024833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anaemia and heart failure: statement of the problem.
    Lewis BS; Karkabi B; Jaffe R; Yuval R; Flugelman MY; Halon DA
    Nephrol Dial Transplant; 2005 Jul; 20 Suppl 7():vii3-6. PubMed ID: 16024830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction between heart failure and other heart diseases, renal failure, and anemia.
    Silverberg DS; Wexler D; Iaina A; Schwartz D
    Semin Nephrol; 2006 Jul; 26(4):296-306. PubMed ID: 16949468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anemia in chronic heart failure: etiology and treatment options.
    Westenbrink BD; de Boer RA; Voors AA; van Gilst WH; van Veldhuisen DJ
    Curr Opin Cardiol; 2008 Mar; 23(2):141-7. PubMed ID: 18303527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New applications of erythropoietin in cardiovascular disease: from haematopoiesis to cardiac protection].
    van der Meer P; van Veldhuisen DJ
    Ned Tijdschr Geneeskd; 2008 Apr; 152(16):923-7. PubMed ID: 18561787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anaemia and the heart.
    Hörl WH; Ertl G
    Eur J Clin Invest; 2005 Dec; 35 Suppl 3():20-5. PubMed ID: 16281954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Erythropoietin: indications and measurement].
    Klein E; Georges A; Brossaud J; Bosredon Kd; Bordenave L; Corcuff JB
    Ann Biol Clin (Paris); 2009; 67(5):505-15. PubMed ID: 19789122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of erythropoietin in anemia after heart transplantation.
    Gleissner CA; Klingenberg R; Staritz P; Koch A; Ehlermann P; Wiggenhauser A; Dengler TJ
    Int J Cardiol; 2006 Oct; 112(3):341-7. PubMed ID: 16309765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Erythropoietin in the treatment of heart failure and ischemia].
    Lewartowski B
    Kardiol Pol; 2007 Feb; 65(2):192-7. PubMed ID: 17366366
    [No Abstract]   [Full Text] [Related]  

  • 13. Anemia and chronic heart failure implications and treatment options.
    Anand IS
    J Am Coll Cardiol; 2008 Aug; 52(7):501-11. PubMed ID: 18687241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human erythropoietin (rHuEPO) therapy in patients with cancer-related anaemia: what have we learned?
    Osterborg A
    Med Oncol; 1998 Aug; 15 Suppl 1():S47-9. PubMed ID: 9785337
    [No Abstract]   [Full Text] [Related]  

  • 15. Anaemia in heart failure: a common interaction with renal insufficiency called the cardio-renal anaemia syndrome.
    Palazzuoli A; Gallotta M; Iovine F; Nuti R; Silverberg DS
    Int J Clin Pract; 2008 Feb; 62(2):281-6. PubMed ID: 18081797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of beta-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with cardiorenal anemia syndrome.
    Leszek P; Kruszewski M
    Am Heart J; 2008 Mar; 155(3):e25; author reply e19. PubMed ID: 18294469
    [No Abstract]   [Full Text] [Related]  

  • 17. Erythropoietin: from molecular biology to clinical use.
    Lacombe C
    Eur Cytokine Netw; 1997 Sep; 8(3):308-10. PubMed ID: 9346370
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful treatment of anaemia of nephrotic syndrome with recombinant human erythropoietin.
    Bayés B; Serra A; Juncà J; Lauzurica R
    Nephrol Dial Transplant; 1998 Jul; 13(7):1894-5. PubMed ID: 9681764
    [No Abstract]   [Full Text] [Related]  

  • 19. [Anemia in lymphoma].
    de La Motte Rouge T; Schneider M
    Bull Cancer; 2005 May; 92(5):429-31. PubMed ID: 15932805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin in cardiac disease: new features of an old drug.
    Ruifrok WP; de Boer RA; Westenbrink BD; van Veldhuisen DJ; van Gilst WH
    Eur J Pharmacol; 2008 May; 585(2-3):270-7. PubMed ID: 18407263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.